Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. - Wikidata - awgldk - TriplyDB

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

http://www.wikidata.org/entity/Q41706476

about

Tuberculosis Biomarkers: From Diagnosis to Protection Year in review 2015: Lung cancer, pleural diseases, respiratory infections, bronchiectasis and tuberculosis, bronchoscopic intervention and imaging Prevalence and Clinical Characteristics of Mycobacterial Diseases in the Barletta-Andria-Trani Province, Italy (2005-2013)HIV-Associated TB Syndemic: A Growing Clinical Challenge Worldwide T-Cell Therapy: Options for Infectious Diseases Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany Update in Mycobacterium tuberculosis lung disease 2014.Tuberculosis in kidney transplant recipients: A case series.Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients.Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age.TLR9 gene region polymorphisms and susceptibility to tuberculosis in Vietnam.Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design.Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay Isoniazid therapy for Mycobacterium tuberculosis infection in HIV clinics, Los Angeles, California Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence.Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6.Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review.Screening and treatment of latent tuberculosis infection among HIV-infected patients in resource-rich settings.New tests for detection of Mycobacterium tuberculosis infection: sufficient to meet the WHO 2035 targets?T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts.Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children.Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.Prognostic value of interferon-γ release assays, a population-based study from a TB low-incidence country.Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.Incidence of tuberculosis is high in chronic kidney disease patients in South East England and drug resistance common.Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients.Poor agreement between diagnostic tests for latent tuberculosis infection among HIV-infected persons in Hong Kong.Superior Sensitivity of Ex Vivo IFN-γ Release Assays as Compared to Skin Testing in Immunocompromised Patients.Immunodiagnostic Tests' Predictive Values for Progression to Tuberculosis in Transplant Recipients: A Prospective Cohort Study.Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis.[Role of GeneXpert MTB/RIF test in the screening for pulmonary tuberculosis at the General Referral Provincial Hospital of Bukavu, in the East of the Democratic Republic of the Congo: balance after 10 months of use].Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice.Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol.Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation.

P2860

Q26741141-A3E382E3-57A7-4A8A-A348-75009E7506FA Q26753069-EE991910-924C-4212-9EBC-7462269EB004 Q26765197-41912120-5E18-4AFC-9C1B-14A9A885C103 Q26771348-E79F01CD-689E-4EC4-890A-4BA516DA31FB Q26786661-9F955796-83B7-4BD6-80F9-F03DD1DB3D5E Q28077155-C138AA92-C8F4-4FC6-BEFC-9157D93F1F6F Q28397652-4FC2A61E-30B2-441E-990F-F061E7B75131 Q33735642-998DA05F-5568-4198-AF88-6D06BC360B14 Q33842806-06FB8BF4-51A4-4645-95A0-51C39D0A317C Q35818931-5BC4A797-841A-4408-9A20-B9AA2740430D Q36040033-4EE4ACF0-0F4E-4975-8D79-AEFE7761F6C8 Q36069508-3DF1D2E9-5EE7-43F6-A024-151267FE3040 Q36120455-761010B3-4B63-4C45-A527-96EFA861186A Q36301207-E88B2136-0969-4153-8E8C-DB60977C81EF Q36302252-F8A22D7F-1F5B-4620-888C-09350C1B3B11 Q36776006-35CF6795-2E95-4CB6-BADC-C1CB2A71417F Q36988815-0183DCED-F7B1-4552-BD0B-BE903F573ABE Q36998816-27BCE87B-8405-41F8-B416-14C7B7211CDF Q37649784-0BFB399D-6E55-4E9A-8E1F-2C2D3EE3AD27 Q37741088-48437F4B-4905-4626-B23E-8573DA742C8C Q38661918-AAA26BC3-45F1-4441-A964-EBBDB0FDA377 Q38670287-AB661CD1-D620-4736-AE91-E62AF637B3BC Q38783382-1F9082FA-FDF3-4C6D-BED3-574FB8ED1678 Q38829376-52A0170A-891B-4752-BD2F-0E98E574DA94 Q39037917-E8A3368A-FA98-41FC-8980-BD129A671C45 Q39352350-43779D7E-4EBE-4254-994E-06C1BF6883D6 Q39381637-5D05DE1E-445E-47A0-8145-316E2CFD49A0 Q39875966-EC963E18-6D31-4C08-99F5-24D36D261025 Q40072142-2883DCC2-A842-4139-B665-4CFCECF709A4 Q40149258-07183D2E-0E95-4F70-9F85-45071D0BD4F8 Q40341751-DBB25DB2-49D9-46C6-B692-62CE88A372BC Q40696371-90CA9AC5-3FDE-4790-929B-5EFE6571C797 Q41201019-309F41B9-4D6E-4AD0-8D70-EE716973AA34 Q41370554-54430D5B-463F-494B-B28B-CC313D73C4E8 Q41436229-B7EF4665-46BD-46C1-A060-B309BF2A58FB Q41683618-14B4D323-E089-42B7-8783-6F4636A2FCFF Q45784038-39E08970-99CA-427C-A3B4-9B3DA51C21BC Q47134742-4A768B91-13EF-4247-AE90-8B3F826A0E8F Q47576115-B483F795-175D-42D3-A973-5F4002039EFA Q48138642-B1BBCAF2-6031-4D06-AE14-F027D26B5A6C

P2860

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

http://www.wikidata.org/entity/Q41706476

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

@en

type

label

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

@en

prefLabel

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

@en

P1433

Q41706476-90D7071A-AFAE-4D79-A0F8-0510CDB14919

P1476

Q41706476-CFCB5F9D-CF73-4E79-A991-F2803EAED121

P2093

Q41706476-112BE86C-F09F-4BA2-BC84-A1EE922F6C85

Q41706476-17C04951-C06C-468D-BD96-E729706DB6E6

Q41706476-22D4A660-71A2-4B58-8991-5B00ACAD125F

Q41706476-2C6934F1-CCA3-482D-831B-464DEC0BFAFA

Q41706476-3A5C8F26-E9EC-4814-B76E-A194C7B5C290

Q41706476-3CF09198-6825-4290-B084-CAFB79FE4EAC

Q41706476-417F7728-A0C6-4D14-8FA4-4B14A92BF48E

Q41706476-45FA2358-71AD-4C04-B7FC-DD6D79F3C001

Q41706476-467AFB52-2AFD-4DD5-8694-D12888B25A96

Q41706476-4CB2B7AC-B355-44BD-88D2-FE886B91EBF3

P2860

Q41706476-0AB30434-F81D-4419-8124-9B457890085F

Q41706476-0CF66345-2B67-41C0-9FC2-09E26BAE9E7F

Q41706476-1BE03777-2C85-4C13-847F-493F7BCEB66C

Q41706476-1CEFDE0D-7393-4B8D-A1CF-FFCC5C2D392D

Q41706476-1F9957D3-BBB6-4B68-B2F7-620A3164B8E8

Q41706476-24437667-FBD2-4DE2-B37E-6AE86488CD7B

Q41706476-3117E0C5-63BA-455A-B102-A677BFE81CCF

Q41706476-48BB78D1-A625-4690-B7C3-D11A2FA1092A

Q41706476-4B2280CC-8204-40E4-B555-13CA76788AC0

Q41706476-4EC04CD0-B4C5-44EF-A4E0-E67362A6C463

P304

Q41706476-C4B6A112-0E3C-440A-97C6-71C39B555CBF

P31

Q41706476-A75E8156-79FF-4609-A965-C6224766310A

P356

Q41706476-FBAD39A6-8887-4006-94C8-46C23B03EA72

P407

Q41706476-1FEED184-14E0-4D5C-BAD1-4E8D454F39F6

P433

Q41706476-6A62DD9A-3AAA-4ED7-8647-A5394D3BE79C

P478

Q41706476-B67F0764-FDA0-4159-AF0E-8065056FA6AD

P50

Q41706476-3453360C-5752-4032-903F-0BBD7BEA3571

Q41706476-8A745556-691C-4E45-9C56-7C1477CD9349

Q41706476-8BF94023-3367-47B2-BD75-71D01E02946E

Q41706476-AB226E1D-C40A-4BFD-8F89-8FED508F7773

Q41706476-C35A0C17-0A2E-4614-9AA1-3F30ABAE501B

Q41706476-D67B097D-95E3-410A-BD67-5A04120AE722

Q41706476-D927E4CF-D702-4BFE-B959-D904AEEDDBA3

Q41706476-DA5D9DCA-3818-43E8-96E6-9883E886FBC4

Q41706476-E30D8323-111A-46D2-87D3-A91589054DC0

P577

Q41706476-17B83FC9-EC9C-4019-91D2-5BDB19853DD4

P698

Q41706476-C46935AC-631D-4807-B9CF-40FBB6334D26

P921

Q41706476-9F637AE0-5C80-4E4C-8FF6-566D0C683D6E

P356

RCCM.201405-0967OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

@en

P2093

Asli Gorek Dilektasli

http://www.w3.org/2001/XMLSchema#string

Aslihan Yalcin

http://www.w3.org/2001/XMLSchema#string

Berit Lange

http://www.w3.org/2001/XMLSchema#string

Daniela M Cirillo

http://www.w3.org/2001/XMLSchema#string

Dragos Bumbacea

http://www.w3.org/2001/XMLSchema#string

Fusun Oner Eyuboglu

http://www.w3.org/2001/XMLSchema#string

Heather Milburn

http://www.w3.org/2001/XMLSchema#string

Inger Julander

http://www.w3.org/2001/XMLSchema#string

Irini Gerogianni

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Janssens

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

The Measurement of Observer Agreement for Categorical Data

Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis

Diagnosis and treatment of latent infection with Mycobacterium tuberculosis

The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis

Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test.

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors.

Discordance among commercially available diagnostics for latent tuberculosis infection.

Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals

Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients.

P304

1168-1176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201405-0967OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

190

http://www.w3.org/2001/XMLSchema#string

P50

Alberto Matteelli

José Domínguez

Christoph Lange

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25303140

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde